Dementia May Be Recognized in Painters by Their Brushstrokes

Neurodegenerative disorders, such as Parkinson’s and Alzheimer’s illnesses influence a huge number of individuals in the United States each year. New research could soon enhance early recognition of these disorders, as researchers may have found an approach to foresee neurological conditions in painters.

A new research published in the journal Neuropsychology may have found a way to identify neurodegenerative disease in patients before they have been formally diagnosed.

Dementia is a typical neurological issue among elderly individuals in the U.S. Neurological disorders falling under the umbrella term “dementia” occur when nerve cells die or can no longer function properly, often resulting in memory loss and impaired reasoning.

Researchers led by psychologist Dr. Alex Forsythe – from the School of Psychology of the University of Liverpool, United Kingdom – analyzed 2,092 paintings by seven famous painters. The team collaborated with Dr. Tamsin Williams, of Tees, Esk, and Wear Valleys NHS Trust, and Dr. Ronan G. Reilly, from Maynooth University in Ireland.

Of the seven artists examined, two (Salvador Dali and Norval Morrisseau) had experienced Parkinson’s disease, while another two (James Brooks and Willem De Kooning) had Alzheimer’s disease.

Three of the artists – Marc Chagall, Pablo Picasso, and Claude Monet – had undergone a normal aging process, with no recorded neurodegenerative diseases.

Continue reading at MedicalNewsToday.

All original content on these pages is fingerprinted and certified by Digiprove